Latest / Stock Movers / Pfizer, DuPont, and Intel Drive Higher
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios, podcasts, radio news, The.
- 0:08Speaker 2: Stock Movers Report, your roundup of companies making moves in
- 0:12Speaker 2: the stock market. Harnessing the power of Bloomberg data.
- 0:16Speaker 3: Let's take a look at some stocks on the move today.
- 0:18Speaker 3: I'm Nathan Hager, joined by Bloomberg's Isabelle Lee, watching the
- 0:22Speaker 3: earnings parade this morning. We've gotten results from Pfizer ahead
- 0:26Speaker 3: of this morning's opening bell. What's the stock reaction?
- 0:29Speaker 2: Is a bell?
- 0:29Speaker 3: Good morning?
- 0:30Speaker 1: Good morning, Nathan. It's kind of muted. The stock is
- 0:32Speaker 1: up by just maybe let's call it two tens of
- 0:35Speaker 1: one percent, so it's a beat for the first quarter sales.
- 0:38Speaker 1: We know that demand for older blockbusters have helped offset
- 0:42Speaker 1: a decline in revenue, so I'm realda wondering why it's
- 0:45Speaker 1: not a bigger pop. But we just had this news,
- 0:47Speaker 1: so maybe investors are still reacting, are still waking up.
- 0:50Speaker 1: We're quarterly sales at fourteen and a half billion dollars.
- 0:53Speaker 1: This is topping Wall Street average. We know that the
- 0:56Speaker 1: blood thinner Elkis and cancer drug padzib drove much of
- 1:01Speaker 1: that demand. The company also reaffirmed their twenty twenty six
- 1:04Speaker 1: sales guidance which is in line with average expectations. So
- 1:08Speaker 1: we know that fires has been working to cut costs
- 1:10Speaker 1: well also building a pipeline that can really push its
- 1:14Speaker 1: next era of growth. But many of the company's top
- 1:16Speaker 1: drugs are really under pressure. It's kind of a really
- 1:19Speaker 1: competitive landscape out there in the medical world.
- 1:22Speaker 3: Well, investors sort of weighed through the results from Pizer.
- 1:25Speaker 3: They've had a little bit more time to digest what
- 1:29Speaker 3: we got from DuPont this morning. Where's that stock going?
- 1:33Speaker 1: DuPont stock, the ticker is dd oh. Now have to
- 1:39Speaker 1: pull it up, hold on, give me ten seconds. Okay, Well,
- 1:43Speaker 1: there it is. Yes, what do you see? I see
- 1:45Speaker 1: one and a half percent? Is that what you see?
- 1:49Speaker 1: A percent? This is a chemical conglomerate, sure, Nathan says,
- 1:53Speaker 1: So shares are arising. The company raised its full year guidance,
- 1:56Speaker 1: and the company has benefited a lot from the whole
- 1:59Speaker 1: price increase that's taken in the wake of the US
- 2:02Speaker 1: around conflict. So it's unfortunate news, but some companies did
- 2:05Speaker 1: benefit from that. The stock is up more than fifteen
- 2:08Speaker 1: percent this year. So the company forecast at twenty twenty
- 2:12Speaker 1: six adjusted EPs of two dollars and thirty five cents
- 2:15Speaker 1: to two dollars and forty cents. This is up ten
- 2:18Speaker 1: cents from the previous range. They also lifted their full
- 2:21Speaker 1: year net sales outlook, and both of the new projections
- 2:25Speaker 1: are above estimate. So DuPont is trying to focus on
- 2:29Speaker 1: businesses and industries including biopharma, medical packaging, and building technologies.
- 2:35Speaker 1: I feel like I always have to know more about
- 2:37Speaker 1: these chemical conglomers because they're really huge companies that affect
- 2:41Speaker 1: the market.
- 2:42Speaker 3: Yeah, totally. And I had to let you know that.
- 2:45Speaker 3: I had to scroll down on my most screen as
- 2:46Speaker 3: well to see that it's up one point six percent.
- 2:48Speaker 3: So okay, good, we learn together. Let's get into some
- 2:53Speaker 3: of the other stocks that have been making a lot
- 2:55Speaker 3: of news this morning, including Intel, because Apple's making news
- 2:59Speaker 3: on that.
- 3:00Speaker 1: Intel is hard to ignore. Exactly it's popping three point
- 3:04Speaker 1: eight percent. This is due to a Bloomberg exclusive, So
- 3:07Speaker 1: we have reporting that Apple has held exploratory discussions about
- 3:11Speaker 1: using Intel as well as Samsung to produce the main
- 3:15Speaker 1: processors for its devices in the US. That's according to
- 3:18Speaker 1: people familiar with the matter. So this would be a
- 3:21Speaker 1: move that would offer a secondary option beyond its longtime
- 3:24Speaker 1: partner TSMC, so Apple executives have made visits to Samsung
- 3:29Speaker 1: plant in Texas that will also make advanced chips. That's
- 3:32Speaker 1: according to the people familiar. And to be clear, neither
- 3:36Speaker 1: efforts has resulted in any order so far, and this
- 3:39Speaker 1: is very preliminary, but you can see investors reacting to this.
- 3:43Speaker 1: We do have this Apple is concerned about using technology
- 3:47Speaker 1: that's non TSMC, and they may ultimately not move forward,
- 3:51Speaker 1: but still investors are reacting. Shares are popping, and Intel
- 3:56Speaker 1: is up around one hundred and sixty percent this year
- 3:59Speaker 1: through Monday close, so you just really see the stock
- 4:02Speaker 1: ripping through the air.
- 4:04Speaker 2: The Stock Movers report from Bloomberg Radio. Check back with
- 4:08Speaker 2: us throughout the day for the latest roundup of companies
- 4:11Speaker 2: making news on Wall Street and for the latest market
- 4:14Speaker 2: moving headlines. Listen to Bloomberg Radio Live, catch us on YouTube,
- 4:18Speaker 2: Bloomberg dot com, and on Applecarplay and Android Auto with
- 4:22Speaker 2: the Bloomberg Business app.